Search form

Sections

AstraZeneca

The Markingson Files: Heads start to roll as clinical trial suicide revelations mount

The University of Minnesota is replacing the chairman of its psychiatry department following two scathing reviews of its safety protocols in research involving human subjects and its recruitment of a troubled man who later died by suicide in a schizophrenia drug trial.

The Markingson Files: University of Minnesota under new scrutiny in drug trial death

Dan Markingson suffered from schizophrenia and killed himself in May 2004 while taking part in a clinical trial for an antipsychotic drug made by AstraZeneca. The evolving case continues to highlight problems of research oversight at the university and state levels.

The American Heart Association--Protecting Industry Not Patients by Barbara Roberts, MD, and Martha Rosenberg

The American Heart Association (AHA) and the American College of Cardiology (ACC) recently released new cardiovascular disease prevention guidelines. They are an egregious example of much that is wrong with medicine today.

Will Risperdal Settlement Change Anything?

Many say the only justice that will get Big Pharma's attention is frog marching the CEOs off to prison and/or cutting them off from their lucrative public trough of Medicare, Medicaid and military health programs.

Doctors report big pharma payouts for drug endorsements

The makers of popular drugs like Advair, Cymbalta, Viagra and Zoloft have physicians, psychiatrists, and medical school faculty members across California on their payrolls. Does this influence prescribing patterns?

Top Prescribers: How One Doctor Made Medi-Cal's Psychiatric Drug List

How does a doctor become a top prescriber of a psychiatric drug in one state’s Medicaid program? A "stunned" California psychiatrist tries to figure out why.

It's Complicated: Taking Conflict of Interest Beyond Pharma Payments to Researchers

I wrote a piece recently for Health News Review about conflicts of interest. The original post is below, followed by more great examples of writers describing unexpected conflicts in detail.

The Markingson Files: Court leaves key questions in clinical trial suicide unanswered

Any investigative reporter will tell you that a case dismissal does not necessarily mean a victory. Here's how that rule of thumb figures into the case of Dan Markingson, who committed suicide after participating in a clinical trial for the psychiatric drug Seroquel.

The Markingson Files: Conflicts of interest in clinical trials should be transparent

It can be uncomfortable asking people about their finances. In journalism, though, there is an obligation not only to ask, but to ask for proof — especially with clinical trials.

Pages

Announcements

We invite you to share your thoughts on Reporting on Health by taking this short survey — your comments and suggestions will help us greatly. Click HERE to begin.

With the explosion of public health data online, more journalists than ever need analytical tools in their daily work. This webinar will teach newcomers how to use a spreadsheet to do simple data cleanup and analysis for journalism. The webinar will be led by Paul Overberg, former data editor of USA Today. More info here.

CONNECT WITH THE COMMUNITY

Member Activities

JOBY KOORAPPILLIL's profile has been updated

Connect with JOBY KOORAPPILLIL

Anna Romano has shared a blog post

Read it.

JoNel Aleccia has shared a blog post

Read it.

Andrea Kobrinsky Alday's profile has been updated

Connect with Andrea Kobrinsky Alday

Phyllis Hanlon joined the community

Connect with Phyllis Hanlon
More Member Activities

Follow Us

ReportingHealth

Reporting on Underserved Communities



How can journalists and foundations collaborate to deepen and improve reporting on underserved communities? Our USC Annenberg School of Journalism program in collaboration with The California Endowment, the Wyncote Foundation and Media Impact Funders, convened 75 leaders from both fields.

Read More »